Paul Lippner

Meridian Medical Technologies LLC develops auto injectors for the pharmaceutical and biotechnological industries. Its product Antidote Treatment Nerve Agent, Auto-Injector is intended as an initial treatment of the symptoms of organophosphorous nerve agent poisoning; additional medical care should be sought as soon as possible. The company was founded in 1968 and is headquartered in Columbia, MD.

Meridian Medical Technologies LLC develops auto injectors for the pharmaceutical and biotechnological industries. Its product Antidote Treatment Nerve Agent, Auto-Injector is intended as an initial treatment of the symptoms of organophosphorous nerve agent poisoning; additional medical care should be sought as soon as possible. The company was founded in 1968 and is headquartered in Columbia, MD.

Meridian Medical Technologies LLC develops auto injectors for the pharmaceutical and biotechnological industries. Its product Antidote Treatment Nerve Agent, Auto-Injector is intended as an initial treatment of the symptoms of organophosphorous nerve agent poisoning; additional medical care should be sought as soon as possible. The company was founded in 1968 and is headquartered in Columbia, MD.

Meridian Medical Technologies LLC develops auto injectors for the pharmaceutical and biotechnological industries. Its product Antidote Treatment Nerve Agent, Auto-Injector is intended as an initial treatment of the symptoms of organophosphorous nerve agent poisoning; additional medical care should be sought as soon as possible. The company was founded in 1968 and is headquartered in Columbia, MD.

Meridian Medical Technologies LLC develops auto injectors for the pharmaceutical and biotechnological industries. Its product Antidote Treatment Nerve Agent, Auto-Injector is intended as an initial treatment of the symptoms of organophosphorous nerve agent poisoning; additional medical care should be sought as soon as possible. The company was founded in 1968 and is headquartered in Columbia, MD.